183 related articles for article (PubMed ID: 18212751)
1. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF
Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
3. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
Bizzarro T; Martini M; Marrocco C; D'Amato D; Traini E; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM; Rossi ED
PLoS One; 2015; 10(7):e0132939. PubMed ID: 26186733
[TBL] [Abstract][Full Text] [Related]
4. Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules.
Henry JF; Denizot A; Porcelli A; Villafane M; Zoro P; Garcia S; De Micco C
World J Surg; 1994; 18(4):529-34. PubMed ID: 7725740
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
[TBL] [Abstract][Full Text] [Related]
6. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
[TBL] [Abstract][Full Text] [Related]
8. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.
Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G
Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
Han RL; Wang J; Zhang FJ; Zhao N; Gao BL
Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
[TBL] [Abstract][Full Text] [Related]
10. Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors.
Maruta J; Hashimoto H; Yamashita H; Noguchi H; Noguchi S; Kobayashi TK; Tsuneoka H; Takahashi M
Diagn Cytopathol; 2015 Mar; 43(3):202-9. PubMed ID: 25195571
[TBL] [Abstract][Full Text] [Related]
11. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G
Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
[TBL] [Abstract][Full Text] [Related]
12. MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules.
Zabegina L; Nazarova I; Knyazeva M; Nikiforova N; Slyusarenko M; Titov S; Vasilyev D; Sleptsov I; Malek A
Cells; 2020 Aug; 9(8):. PubMed ID: 32824820
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
Torregrossa L; Faviana P; Filice ME; Materazzi G; Miccoli P; Vitti P; Fontanini G; Melillo RM; Santoro M; Basolo F
Thyroid; 2010 May; 20(5):495-504. PubMed ID: 20450430
[TBL] [Abstract][Full Text] [Related]
14. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
[TBL] [Abstract][Full Text] [Related]
15. Immune characterization of thyroid neoplasm's and its variants using immunohistochemical markers: CK-19, Galectin-3 and Hector Battifora mesothelial-1.
Nehal S; Mittal R; Misra P; Rath J; Senapati U
Ann Diagn Pathol; 2022 Jun; 58():151931. PubMed ID: 35255428
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration.
Faroux MJ; Theobald S; Pluot M; Patey M; Menzies D
Pathol Res Pract; 1997; 193(10):705-12. PubMed ID: 9505263
[TBL] [Abstract][Full Text] [Related]
17. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule.
Christensen L; Blichert-Toft M; Brandt M; Lange M; Sneppen SB; Ravnsbaek J; Mollerup CL; Strange L; Jensen F; Kirkegaard J; Sand Hansen H; Sørensen SS; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2000 Aug; 53(2):161-9. PubMed ID: 10931096
[TBL] [Abstract][Full Text] [Related]
18. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
[TBL] [Abstract][Full Text] [Related]
20. Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.
Arcolia V; Journe F; Renaud F; Leteurtre E; Gabius HJ; Remmelink M; Saussez S
Oncol Lett; 2017 Oct; 14(4):4183-4189. PubMed ID: 28943926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
